Kohjin Bio Co., Ltd.
177Aコージンバイオ株式会社
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-13For the first half of the fiscal year to 2026-03: Revenue ¥2.5 billion (-0.1% YoY), Ordinary income ¥0.3 billion (-34.8% YoY), Net income ¥0.2 billion (-27.1% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥2.5bn | -0.1% |
| Ordinary profit | ¥272m | -34.8% |
| Net profit to owners | ¥202m | -27.1% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/177A/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥4.9bn
- Net income
- ¥251m
- ROE
- 4.3%
- Equity ratio
- 66.8%
- Dividend / share
- ¥10
- Employees
- 176
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥4,939m | ¥251m | ¥8,904m | ¥5,945m | 4.3% | ¥49.11 | ¥699m |
| 2025-03-31 | ¥5,206m | ¥795m | ¥9,067m | ¥5,782m | 17.4% | ¥157.57 | ¥916m |
| 2024-03-31 | ¥4,770m | ¥385m | ¥6,589m | ¥3,342m | 12.1% | ¥92.43 | ¥824m |
| 2023-03-31 | ¥4,743m | ¥830m | ¥6,135m | ¥3,018m | 31.7% | ¥199.23 | ¥461m |
| 2022-03-31 | ¥3,947m | ¥588m | ¥5,595m | ¥2,217m | 31.2% | ¥173.5 | ¥763m |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 4.3 | 20.8 |
| Ordinary margin | 0.069 | 50.4 |
| Equity ratio, % | 66.8 | 69 |
| Revenue growth | -0.0513 | 11.7 |
| Net income growth | -0.6842 | 9.8 |
| Operating cash flow / assets | 0.0784 | 60.1 |
Results wording balance: -0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥1.9bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥9m, 1.3% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/177A/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/177A/segments/v1/companies/177A/votingOwnership changes
All companies →- 2025-09-08
Gordian Capital Singapore Private Limited raised holdings in Kohjin Bio Co., Ltd. (177A) to 7.11% from 6.02%.
- 2025-06-10
Gordian Capital Singapore Private Limited raised holdings in Kohjin Bio Co., Ltd. (177A) to 6.02% from 5.01%.
- 2025-01-10
Gordian Capital Singapore Private Limited disclosed a 5.01% stake in Kohjin Bio Co., Ltd. (177A), crossing the 5% reporting threshold.
- 2024-05-02
individual filer disclosed a 53.86% stake in Kohjin Bio Co., Ltd. (177A), crossing the 5% reporting threshold.
- 2024-05-02
Holdings of individual filer in Kohjin Bio Co., Ltd. (177A) moved above 10% (new -> 53.86%).
- 2024-05-02
Holdings of individual filer in Kohjin Bio Co., Ltd. (177A) moved above 20% (new -> 53.86%).
- 2024-05-02
Holdings of individual filer in Kohjin Bio Co., Ltd. (177A) moved above 33.4% (new -> 53.86%).
- 2024-05-02
Holdings of individual filer in Kohjin Bio Co., Ltd. (177A) moved above 50% (new -> 53.86%).
- 2024-05-02
Oriental Yeast Co., Ltd. disclosed a 5.38% stake in Kohjin Bio Co., Ltd. (177A), crossing the 5% reporting threshold.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| Gordian Capital Singapore Private Limited | 2024-10-29 – 2025-09-01 | +133,700 | +2.62pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/177A/trades.
5% filings
Large shareholding reports on 177A| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2025-09-08 | Gordian Capital Singapore Private Limited | 7.11% | +1.09pt | pure investment |
| 2025-06-10 | Gordian Capital Singapore Private Limited | 6.02% | +1.01pt | pure investment |
| 2025-01-10 | Gordian Capital Singapore Private Limited | 5.01% | — | pure investment |
| 2024-05-02 | individual filer | 53.86% | — | — |
| 2024-05-02 | Oriental Yeast Co., Ltd. | 5.38% | — | strategic holding |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥8m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 1
- Held by listed cos.
- 1
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| COSMO BIO COMPANY, LIMITED 3386 | ¥8m | 0.0% | both reports |
Held by: COSMO BIO COMPANY, LIMITED 3386
Purposes, all holdings and mutual flags via /v1/companies/177A/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 2,209,500 | 43.20% |
| TAKAコーポレーション株式会社 | 416,500 | 8.20% |
| individual holder | 389,478 | 7.60% |
| オリエンタル酵母工業株式会社 | 270,000 | 5.30% |
| BNY GCM CLIENT ACCOUNT JPRD AC ISG （FE－AC） | 228,452 | 4.50% |
| 富士フイルム和光純薬株式会社 | 140,000 | 2.70% |
| コージンバイオ従業員持株会 | 118,579 | 2.30% |
| コスモ・バイオ株式会社 | 100,000 | 2.00% |
| individual holder | 78,900 | 1.50% |
| 家田化学薬品株式会社 | 72,000 | 1.40% |
Get this as JSON
GET /v1/companies/177A
GET /v1/companies/177A/financials
GET /v1/companies/177A/details
GET /v1/companies/177A/segments
GET /v1/companies/177A/voting
GET /v1/companies/177A/tender-offers
GET /v1/companies/177A/indicators
GET /v1/companies/177A/earnings-releases
GET /v1/events?ticker=177A
GET /v1/companies/177A/trades
GET /v1/companies/177A/cross-holdings
GET /v1/companies/177A/brief